Pancreas removal with islet transplant for high-risk tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial removes the whole pancreas in people with certain pancreatic tumors and then transplants the patient's own insulin-making cells (islets) into the liver. The goal is to prevent or reduce diabetes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a tumor in the area around the pancreas that requires surgery to remove part of the pancreas and nearby organs.
- Your main pancreatic duct is small (2 mm or less) and your pancreas is soft, based on scans.
- Your body still makes enough insulin (measured by a C-peptide test) to make the islet transplant worthwhile.
- You are not pregnant, not using alcohol or drugs heavily, and do not have poorly controlled mental illness.
- Your body mass index (BMI) is 35 or lower, and you have no blood clots or high pressure in the liver veins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing the entire pancreas (total pancreatectomy) versus removing only the head (standard Whipple) for certain cancers of the pancreas, bile duct, or ampulla. It is for people whose surgeon thinks the pancreas connection after surgery is likely to leak, which can cause serious complications.
This trial tests a specific surgical method called mesopancreatic excision during Whipple surgery for pancreatic cancer. It may help remove more cancer tissue and improve outcomes for patients with resectable disease.
This study tests a surgery that removes the entire pancreas and then transplants your own insulin-making cells (islet cells) back into your liver. It aims to relieve chronic pancreatitis pain while reducing the risk of diabetes.
This Phase 1/2 study tests whether adding an islet (insulin-producing cell) transplant at the time of pancreatic-region surgery is safe and helps prevent a serious surgical complication called a postoperative fistula. It is for people whose surgery is considered high risk for developing that complication.
This Phase 3 trial studies a pancreatic surgery approach (pylorus-preserving Whipple or similar) and, in some cases, moving your insulin-making cells into your body to help prevent a dangerous post-surgery leak from the pancreas. It may help people who are considered high risk for this complication based on pancreas texture and duct size.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.